RPRX logo

Royalty Pharma plc (RPRX) Cash From Operations

Annual CFO:

$2.79B-$239.06M(-7.89%)
December 31, 2024

Summary

  • As of today, RPRX annual cash from operations is $2.79 billion, with the most recent change of -$239.06 million (-7.89%) on December 31, 2024.
  • During the last 3 years, RPRX annual cash from operations has risen by +$774.57 million (+38.38%).
  • RPRX annual cash from operations is now -7.89% below its all-time high of $3.03 billion, reached on December 31, 2023.

Performance

RPRX Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRPRXcash flow metrics

Quarterly CFO:

$703.52M+$276.55M(+64.77%)
September 30, 2025

Summary

  • As of today, RPRX quarterly cash from operations is $703.52 million, with the most recent change of +$276.55 million (+64.77%) on September 30, 2025.
  • Over the past year, RPRX quarterly cash from operations has dropped by -$11.58 million (-1.62%).
  • RPRX quarterly cash from operations is now -34.16% below its all-time high of $1.07 billion, reached on March 31, 2023.

Performance

RPRX Quarterly Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRPRXcash flow metrics

TTM CFO:

$2.51B-$11.58M(-0.46%)
September 30, 2025

Summary

  • As of today, RPRX TTM cash from operations is $2.51 billion, with the most recent change of -$11.58 million (-0.46%) on September 30, 2025.
  • Over the past year, RPRX TTM cash from operations has dropped by -$315.54 million (-11.17%).
  • RPRX TTM cash from operations is now -17.25% below its all-time high of $3.03 billion, reached on December 31, 2023.

Performance

RPRX TTM Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRPRXcash flow metrics

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

RPRX Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-7.9%-1.6%-11.2%
3Y3 Years+38.4%+30.6%+21.5%
5Y5 Years+67.5%+38.3%+27.8%

RPRX Cash From Operations Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-7.9%+38.4%-34.2%+64.8%-17.3%+21.5%
5Y5-Year-7.9%+67.5%-34.2%+64.8%-17.3%+28.5%
All-TimeAll-Time-7.9%+113.9%-34.2%+108.8%-17.3%+479.5%

RPRX Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2025
-
$703.52M(+64.8%)
$2.51B(-0.5%)
Jun 2025
-
$426.97M(-32.5%)
$2.52B(-8.5%)
Mar 2025
-
$632.34M(-15.2%)
$2.76B(-1.3%)
Dec 2024
$2.79B(-7.9%)
$745.77M(+4.3%)
$2.79B(-1.1%)
Sep 2024
-
$715.10M(+8.0%)
$2.82B(+5.1%)
Jun 2024
-
$662.15M(-1.1%)
$2.69B(+2.1%)
Mar 2024
-
$669.60M(-13.9%)
$2.63B(-13.2%)
Dec 2023
$3.03B(+41.4%)
$777.28M(+34.5%)
$3.03B(+7.3%)
Sep 2023
-
$577.98M(-4.9%)
$2.82B(+1.4%)
Jun 2023
-
$607.82M(-43.1%)
$2.79B(+1.2%)
Mar 2023
-
$1.07B(+87.5%)
$2.75B(+28.4%)
Dec 2022
$2.14B(+6.2%)
$569.93M(+5.8%)
$2.14B(+3.9%)
Sep 2022
-
$538.83M(-6.3%)
$2.06B(+3.5%)
Jun 2022
-
$574.95M(+24.9%)
$1.99B(+2.2%)
Mar 2022
-
$460.27M(-6.1%)
$1.95B(-3.3%)
DateAnnualQuarterlyTTM
Dec 2021
$2.02B(-1.5%)
$489.96M(+4.3%)
$2.02B(-3.6%)
Sep 2021
-
$469.76M(-11.7%)
$2.09B(-1.8%)
Jun 2021
-
$532.24M(+1.2%)
$2.13B(+1.3%)
Mar 2021
-
$526.10M(-7.0%)
$2.10B(+2.7%)
Dec 2020
$2.05B(+22.9%)
$565.67M(+11.2%)
$2.05B(+4.4%)
Sep 2020
-
$508.85M(+0.9%)
$1.96B(+4.8%)
Jun 2020
-
$504.09M(+7.0%)
$1.87B(+9.8%)
Mar 2020
-
$471.10M(-1.5%)
$1.71B(+2.3%)
Dec 2019
$1.67B(+3.0%)
$478.43M(+14.2%)
$1.67B(+40.2%)
Sep 2019
-
$419.03M(+24.4%)
$1.19B(+54.4%)
Jun 2019
-
$336.88M(-22.2%)
$769.78M(+77.8%)
Mar 2019
-
$432.89M
$432.89M
Dec 2018
$1.62B(+14.1%)
-
-
Dec 2017
$1.42B(-4.3%)
-
-
Dec 2016
$1.48B(+13.5%)
-
-
Dec 2015
$1.31B
-
-

FAQ

  • What is Royalty Pharma plc annual cash from operations?
  • What is the all-time high annual cash from operations for Royalty Pharma plc?
  • What is Royalty Pharma plc annual cash from operations year-on-year change?
  • What is Royalty Pharma plc quarterly cash from operations?
  • What is the all-time high quarterly cash from operations for Royalty Pharma plc?
  • What is Royalty Pharma plc quarterly cash from operations year-on-year change?
  • What is Royalty Pharma plc TTM cash from operations?
  • What is the all-time high TTM cash from operations for Royalty Pharma plc?
  • What is Royalty Pharma plc TTM cash from operations year-on-year change?

What is Royalty Pharma plc annual cash from operations?

The current annual cash from operations of RPRX is $2.79B

What is the all-time high annual cash from operations for Royalty Pharma plc?

Royalty Pharma plc all-time high annual cash from operations is $3.03B

What is Royalty Pharma plc annual cash from operations year-on-year change?

Over the past year, RPRX annual cash from operations has changed by -$239.06M (-7.89%)

What is Royalty Pharma plc quarterly cash from operations?

The current quarterly cash from operations of RPRX is $703.52M

What is the all-time high quarterly cash from operations for Royalty Pharma plc?

Royalty Pharma plc all-time high quarterly cash from operations is $1.07B

What is Royalty Pharma plc quarterly cash from operations year-on-year change?

Over the past year, RPRX quarterly cash from operations has changed by -$11.58M (-1.62%)

What is Royalty Pharma plc TTM cash from operations?

The current TTM cash from operations of RPRX is $2.51B

What is the all-time high TTM cash from operations for Royalty Pharma plc?

Royalty Pharma plc all-time high TTM cash from operations is $3.03B

What is Royalty Pharma plc TTM cash from operations year-on-year change?

Over the past year, RPRX TTM cash from operations has changed by -$315.54M (-11.17%)
On this page